Your browser doesn't support javascript.
loading
HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma.
Yassin, Rehab; Hajeer, Ali; Alshieban, Saeed; Syed, Ghulam; Alahmari, Bader; Alhejazi, Ayman; Alaskar, Ahmed; Alzahrani, Mohsen; Damlaj, Moussab.
Afiliação
  • Yassin R; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Hajeer A; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alshieban S; Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Syed G; Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alahmari B; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alhejazi A; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alaskar A; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alzahrani M; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Damlaj M; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. Electronic address: damlajmo@ngha.med
Curr Res Transl Med ; 67(1): 31-33, 2019 02.
Article em En | MEDLINE | ID: mdl-30448276

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Resistencia a Medicamentos Antineoplásicos / Nivolumabe / Antígenos HLA / Neoplasias do Mediastino Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Resistencia a Medicamentos Antineoplásicos / Nivolumabe / Antígenos HLA / Neoplasias do Mediastino Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article